Effects of Fast Bar on Intermittent Fasting
FastBar2
The Effects of Fast Bar on Facilitating Prolonged Fasting - a Randomized, Controlled, Parallel-arm Study
2 other identifiers
interventional
89
1 country
1
Brief Summary
This study evaluates how Fast Bar(TM), a specially formulated energy bar, when consumed with coffee or tea, affects the physiological condition in participants after an overnight fasting. Participants will fast for 19 hours (Fast Group), consume a Fast Bar in the night (Night Bar Group) or in the morning (Bar+Coffee and Bar+Tea Groups) after an approximately 15-hour overnight fasting. Participants will be assessed for physiological parameters associated with fasting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2021
CompletedFirst Submitted
Initial submission to the registry
March 6, 2021
CompletedFirst Posted
Study publicly available on registry
March 10, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 14, 2021
CompletedSeptember 9, 2021
September 1, 2021
5 months
March 6, 2021
September 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Ketone level
Blood ketone (ß-hydroxybutyrate, BHB) level (mg/dL) will be measured with a Abbott Precision Xtra Blood Glucose and Ketone Monitoring Kit.
3 hours after consuming the study foods (Fast Bar with coffee or tea)
Ketone Area Under the Curve
Blood ketone (ß-hydroxybutyrate, BHB) area under the curve (AUC) will be measured with a Abbott Precision Xtra Blood Glucose and Ketone Monitoring Kit on 0, 1, 2, 3, and 4 hours after consuming the study foods.
BHB Area Under the Curve between 0 to 4 hours after consuming the study foods
Glucose Area Under the Curve
Blood glucose area under the curve (AUC) will be measured with a Abbott Precision Xtra Blood Glucose and Ketone Monitoring Kit on 0, 1, 2, 3, and 4 hours after consuming the study foods
Glucose Area Under the Curve between 0 to 4 hours after consuming the study foods
Secondary Outcomes (2)
Food evaluation
1 hour after consuming the study foods
Self-evaluation
1 hour after consuming the study foods
Study Arms (4)
Fast Group
ACTIVE COMPARATORSubjects will be asked to consume a standardized ready-to-eat dinner meal before 5 pm on day 1. Subjects will fast overnight for approximately 19 hours.
Night Bar Group
EXPERIMENTALSubjects will be asked to consume a standardized ready-to-eat dinner meal before 5 pm on day 1. Subjects will consume a Fast Bar 3 hours after the dinner and then fast overnight. Subjects will fast overnight for approximately 15 hours and then consume a Fast Bar with coffee on day 2.
Bar + Coffee Group
EXPERIMENTALSubjects will be asked to consume a standardized ready-to-eat dinner meal before 5 pm on day 1. Subjects will fast overnight for approximately 15 hours and then consume a Fast Bar with coffee on day 2.
Bar + Tea Group
EXPERIMENTALSubjects will be asked to consume a standardized ready-to-eat dinner meal before 5 pm on day 1. Subjects will fast overnight for approximately 15 hours and then consume a Fast Bar with tea on day 2.
Interventions
Eligibility Criteria
You may qualify if:
- Ability and willingness to provide written informed consent;
- Ability and willingness to use Zoom teleconference;
- Ability and willingness to perform the study tests and adhere to study protocol to the best of the participant's knowledge;
- years of age (inclusive) at screening;
- BMI 20-35 kg/m2 (inclusive) at screening;
- In good health (as determined by medical history to evaluate acute or ongoing chronic medical diagnoses/conditions that have been present for at least 90 days);
- Habitual breakfast eater (determined with a screening survey: number of breakfasts per week ≥4.
You may not qualify if:
- Has any medical disease or condition that, in the opinion of the principal investigator (PI) or appropriate study personnel, precludes study participation\* (\*Including acute, subacute, intermittent or chronic medical disease or condition that would place the subject at an unacceptable risk of injury, render the subject unable to meet the requirements of the protocol, or may interfere with the evaluation of responses or the subject's successful completion of this trial);
- History of gastric bypass (based on medical history provided at screening);
- Under medications aimed at keeping blood glucose under control (based on medical history provided at screening);
- Type 1 diabetes (based on medical history provided at screening);
- Taking insulin, insulin analogs, or octreotide (based on medical history provided at screening);
- Food allergies which would make the subject unable to consume the food provided (based on medical history and information provided at screening) (participants will be asked to review the ingredient lists for the dinner meal and the Fast BarTM, and to state that they are not allergic to the ingredients to the best of their knowledge);
- Women who are pregnant;
- Alcohol dependency (alcohol intake greater than two drinks per day for women and three drinks per day for men) (based on medical history and information provided at screening).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- L-Nutra Inclead
Study Sites (1)
L-Nutra Inc.
Los Angeles, California, 90048, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William Hsu, MD
L-Nutra Inc
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 6, 2021
First Posted
March 10, 2021
Study Start
March 1, 2021
Primary Completion
August 1, 2021
Study Completion
August 14, 2021
Last Updated
September 9, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share